INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

1984 • 667 citations

HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA

1983 • 515 citations

Failure to detect antibody against Gross virus in tetraparental AKR ↔ CBA mouse chimaeras

1975 • 348 citations

Multiple myeloma treated with high dose intravenous melphalan

1987 • 251 citations

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

1988 • 163 citations

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.

1983 • 156 citations

Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay

1983 • 147 citations

Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

1986 • 83 citations

Results of the mrc myelomatosis trials for patients entered since 1980

1988 • 53 citations

INCREASE IN CLONOGENIC TUMOUR CELLS IN BONE MARROW OF PATIENTS WITH MULTIPLE MYELOMA TREATED WITH VINCRISTINE, DOXORUBICIN, AND METHYLPREDNISOLONE

1988 • 14 citations